Quick facts
- Also called: a proxy contest
- The prize: board seats, won by vote rather than by purchase
- Federal rules: Regulation 14A, including the universal proxy rule
- Notice deadline: 60 days before the anniversary of last year's meeting
- Solicitation floor: holders of at least 67% of the voting power
A proxy fight is a campaign to win seats on a company's board by persuading other shareholders to vote for your nominees instead of the board's. A "proxy" is simply the authority to cast someone else's vote, which is how nearly all shareholder voting actually happens.
It is the route to control that does not require buying the company.
In plain English
There are two ways to take control of a public company. Buy enough shares, which is expensive and can be blocked by a poison pill. Or convince the people who already own the shares to vote your way, which is cheaper and cannot be blocked by a pill at all.
A proxy fight is the second route. You are not buying the company. You are running a campaign.
Why votes are the currency
Delaware's default is one vote per share: "each stockholder shall be entitled to 1 vote for each share of capital stock held by such stockholder," unless the certificate of incorporation says otherwise.3
That default is why share ownership and voting power usually move together, and why dual-class structures, which depart from it, are such an effective defence against this entire manoeuvre.
What actually happens
- A shareholder concludes the board is failing and nominates an alternative slate.
- They file a proxy statement with the Securities and Exchange Commission and notify the company.
- Both sides solicit votes from the shareholder base, particularly the large institutions that hold most of the stock.
- The votes are counted at the annual meeting.
- Whoever wins the seats takes them.
The universal proxy card, and why 2022 matters
This is the part most explanations still get wrong, because the rules changed.
Previously each side circulated its own card, and a shareholder had to pick one. You could vote for management's whole slate or the challenger's whole slate, but mixing them was impractical. That structure favoured incumbents.
Rule 14a-19 changed it. Anyone soliciting proxies "in support of director nominees other than the registrant's nominees" must now satisfy several requirements:1
- Notice to the company, "no later than 60 calendar days prior to the anniversary of the previous year's annual meeting date"
- File a definitive proxy statement by the later of 25 calendar days before the meeting, or five days after the company files its own
- Solicit holders representing at least 67% of the voting power of shares entitled to vote in the election, and say so in the proxy statement
The effect is that shareholders can now mix and match, backing two of the challenger's nominees and the rest of the board's. A dissident no longer has to persuade anyone to replace the entire board. They only have to make the case for one or two individuals.
That lowered the bar considerably, and the 67% solicitation requirement is the trade: to use the card, you must run a real campaign rather than a token one.
What the ballot looks like
The federal rules also govern the card itself. A proxy form for director elections must let holders withhold authority to vote for nominees, or, "when applicable state law gives legal effect to votes cast against a nominee," vote against them and abstain.2
Whether "against" appears at all depends on whether the company uses majority voting. Under plurality, withholding is a gesture. Under majority voting, it is a weapon.
Why they are hard to win
The share register is concentrated. A handful of large asset managers hold enough stock to decide most contests, so the campaign is really a series of meetings with a small number of institutions, followed by a much noisier public campaign aimed at influencing them.
Proxy advisory firms matter for the same reason: many institutions lean on their analysis when voting across thousands of meetings.
What slows an attacker down
A staggered board is the strongest structural answer. If only one class of directors stands for election each year, winning every contested seat still does not deliver control, and the challenger must come back and win again. The poison pill stays in place throughout, because only the directors they have not yet replaced can redeem it.
This is why a bidder facing both structures is looking at a campaign measured in years.
Proxy fight compared with tender offer
| Proxy fight | Tender offer | |
|---|---|---|
| What you are seeking | Board seats | Shares |
| Decided by | A vote | Shareholders choosing to sell |
| Capital required | Campaign costs | Enough to buy control |
| Blocked by a pill | No | Yes |
| Speed | Tied to the meeting calendar | Faster, if unobstructed |
The two are often run together: a tender offer to establish the economics, and a proxy fight to replace the directors who would otherwise refuse it.
What this means for a founder
Private companies do not have proxy fights, because board seats are allocated by contract rather than won by vote. Your equivalent is the voting agreement.
The transferable question is who your investors would vote with. Proxy contests turn on a small number of large holders, and so does your cap table. If the people holding your preferred stock decided together that the company needed a different chief executive, the mechanism would not be a campaign. It would be a clause.
Read the hostile takeover guide for how this sits alongside the other routes to control.
Related reading
- Poison Pill covers the defence a proxy fight is designed to go around
- Staggered Board covers the structure that doubles the time required
- Tender Offer covers buying control instead of voting for it
- Majority Voting covers whether a withheld vote actually counts